Hossein Aboutalebi

Hossein Aboutalebi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
HAHossein Aboutalebi
Hossein Aboutalebi
MPMaya Pavlova
Maya Pavlova
MSMohammad Javad Shafiee
Mohammad Javad Shafiee
ASAli Sabri
Ali Sabri
AAAmer Alaref
Amer Alaref
Alexander WongAlexander Wong
Alexander Wong
The world is still struggling in controlling and containing the spread of the COVID-19 pandemic caused by the SARS-CoV-2 virus. The medical conditions associated with SARS-CoV-2 infections have resulted in a surge in the number of patients at clinics and hospitals, leading to a significantly increased strain on healthcare resources. As such, an important part of managing and handling patients with SARS-CoV-2 infections within the clinical workflow is severity assessment, which is often conducted with the use of chest X-ray (CXR) images. In this work, we introduce COVID-Net CXR-S, a convolutional neural network for predicting the airspace severity of a SARS-CoV-2 positive patient based on a CXR image of the patient’s chest. More specifically, we leveraged transfer learning to transfer representational knowledge gained from over 16,000 CXR images from a multinational cohort of over 15,000 SARS-CoV-2 positive and negative patient cases into a custom network architecture for severity assessment. Experimental results using the RSNA RICORD dataset showed that the proposed COVID-Net CXR-S has potential to be a powerful tool for computer-aided severity assessment of CXR images of COVID-19 positive patients. Furthermore, radiologist validation on select cases by two board-certified radiologists with over 10 and 19 years of experience, respectively, showed consistency between radiologist interpretation and critical factors leveraged by COVID-Net CXR-S for severity assessment. While not a production-ready solution, the ultimate goal for the open source release of COVID-Net CXR-S is to act as a catalyst for clinical scientists, machine learning researchers, as well as citizen scientists to develop innovative new clinical decision support solutions for helping clinicians around the world manage the continuing pandemic.

29 June 2021 in Research Square
Verified
Preprint
Open access
PDF file
HAHossein Aboutalebi
Hossein Aboutalebi
MPMaya Pavlova
Maya Pavlova
MSMohammad Javad Shafiee
Mohammad Javad Shafiee
ASAli Sabri
Ali Sabri
AAAmer Alaref
Amer Alaref
AWAlexander Wong
Alexander Wong
The world is still struggling in controlling and containing the spread of the COVID-19 pandemic caused by the SARS-CoV-2 virus. The medical conditions associated with SARS-CoV-2 infections have resulted in a surge in the number of patients at clinics and hospitals, leading to a significantly increased strain on healthcare resources. As such, an important part of managing patients with SARS-CoV-2 infections within the clinical workflow is severity assessment, which is often conducted with the use of chest x-ray (CXR) images. In this work, we introduce COVID-Net CXR-S, a convolutional neural network for predicting the airspace severity of a SARS-CoV-2 positive patient based on a CXR image of the patient's chest. More specifically, we leveraged transfer learning to transfer representational knowledge gained from over 16,000 CXR images from a multinational cohort of over 15,000 patient cases into a custom network architecture for severity assessment. Experimental results with a multi-national patient cohort curated by the Radiological Society of North America (RSNA) RICORD initiative showed that the proposed COVID-Net CXR-S has potential to be a powerful tool for computer-aided severity assessment of CXR images of COVID-19 positive patients. Furthermore, radiologist validation on select cases by two board-certified radiologists with over 10 and 19 years of experience, respectively, showed consistency between radiologist interpretation and critical factors leveraged by COVID-Net CXR-S for severity assessment. While not a production-ready solution, the ultimate goal for the open source release of COVID-Net CXR-S is to act as a catalyst for clinical scientists, machine learning researchers, as well as citizen scientists to develop innovative new clinical decision support solutions for helping clinicians around the world manage the continuing pandemic.

1 January 2024
Verified
Conference Paper
Open access
PDF file
HAHossein Aboutalebi
Hossein Aboutalebi
HSHwanjun Song
Hwanjun Song
YXYusheng Xie
Yusheng Xie
AGArshit Gupta
Arshit Gupta
LSLijia Sun
Lijia Sun
SMSaab Mansour
Saab Mansour
Hossein Aboutalebi, Hwanjun Song, Yusheng Xie, Arshit Gupta, Lijia Sun, Hang Su, Igor Shalyminov, Nikolaos Pappas, Siffi Singh, Saab Mansour. Proceedings of the 2024 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies (Volume 1: Long Papers). 2024.

9 October 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HAHossein Aboutalebi
Hossein Aboutalebi
MPMaya Pavlova
Maya Pavlova
MSMohammad Javad Shafiee
Mohammad Javad Shafiee
AFAdrian Florea
Adrian Florea
AHAndrew Hryniowski
Andrew Hryniowski
AWAlexander Wong
Alexander Wong
Since the World Health Organization declared COVID-19 a pandemic in 2020, the global community has faced ongoing challenges in controlling and mitigating the transmission of the SARS-CoV-2 virus, as well as its evolving subvariants and recombinants. A significant challenge during the pandemic has not only been the accurate detection of positive cases but also the efficient prediction of risks associated with complications and patient survival probabilities. These tasks entail considerable clinical resource allocation and attention. In this study, we introduce COVID-Net Biochem, a versatile and explainable framework for constructing machine learning models. We apply this framework to predict COVID-19 patient survival and the likelihood of developing Acute Kidney Injury during hospitalization, utilizing clinical and biochemical data in a transparent, systematic approach. The proposed approach advances machine learning model design by seamlessly integrating domain expertise with explainability tools, enabling model decisions to be based on key biomarkers. This fosters a more transparent and interpretable decision-making process made by machines specifically for medical applications. More specifically, the framework comprises two phases: In the first phase, referred to as the “clinician-guided design” phase, the dataset is preprocessed using explainable AI and domain expert input. To better demonstrate this phase, we prepared a benchmark dataset of carefully curated clinical and biochemical markers based on clinician assessments for survival and kidney injury prediction in COVID-19 patients. This dataset was selected from a patient cohort of 1366 individuals at Stony Brook University. Moreover, we designed and trained a diverse collection of machine learning models, encompassing gradient-based boosting tree architectures and deep transformer architectures, specifically for survival and kidney injury prediction based on the selected markers. In the second phase, called the “explainability-driven design refinement” phase, the proposed framework employs explainability methods to not only gain a deeper understanding of each model’s decision-making process but also to identify the overall impact of individual clinical and biochemical markers for bias identification. In this context, we used the models constructed in the previous phase for the prediction task and analyzed the explainability outcomes alongside a clinician with over 8 years of experience to gain a deeper understanding of the clinical validity of the decisions made. The explainability-driven insights obtained, in conjunction with the associated clinical feedback, are then utilized to guide and refine the training policies and architectural design iteratively. This process aims to enhance not only the prediction performance but also the clinical validity and trustworthiness of the final machine learning models. Employing the proposed explainability-driven framework, we attained 93.55% accuracy in survival prediction and 88.05% accuracy in predicting kidney injury complications. The models have been made available through an open-source platform. Although not a production-ready solution, this study aims to serve as a catalyst for clinical scientists, machine learning researchers, and citizen scientists to develop innovative and trustworthy clinical decision support solutions, ultimately assisting clinicians worldwide in managing pandemic outcomes.

25 December 2023 in IEEE Access
Verified
Journal Article
Open access
HAHossein Aboutalebi
Hossein Aboutalebi
MSMohammad Javad Shafiee
Mohammad Javad Shafiee
CTChi-en Tai
Chi-en Tai
Alexander WongAlexander Wong
Alexander Wong
Significant advances have been made in recent years in improving the robustness of deep neural networks, particularly under adversarial machine learning scenarios where the data has been contaminated to fool networks into making undesirable predictions. However, such improvements in adversarial robustness has often come at a significant cost in model accuracy when dealing with uncontaminated data (i.e., clean data), making such defense mechanisms challenging to adapt for real-world practical scenarios where data is primarily clean and accuracy needs to be high. Motivated to find a better balance between adversarial robustness and clean data accuracy, we propose a new model-agnostic adversarial defense mechanism named Dual-model Bounded Divergence (DBD), driven by a theoretical and empirical analysis of the bias-variance trade-off within an adversarial machine learning context. More specifically, the proposed DBD mechanism is premised on the observation that the variance in deep neural networks tends to increase in the presence of adversarial perturbations in the input data. As such, DBD employs a gating mechanism to decide on the final model prediction output based on a novel dual-model variance measure (coined DBD Variance), which is a bounded version of KL-Divergence between models. Not only is the proposed DBD mechanism itself training-free, but it can be combined with existing adversarial defense mechanisms to boost the balance between clean data accuracy and adversarial robustness. Comprehensive experimental results across over 10 different state-of-the-art adversarial defense mechanisms using both CIFAR-10 and ImageNet benchmark datasets across different adversarial attacks (e.g., APGD, AutoAttack) demonstrates that the integration of DBD can lead to as much as a 6% improvement on clean data accuracy without compromising much on adversarial robustness.

16 November 2022 in arXiv
Verified
Preprint
Open access
PDF file
MGMaziar Gomrokchi
Maziar Gomrokchi
SASusan Amin
Susan Amin
HAHossein Aboutalebi
Hossein Aboutalebi
Alexander WongAlexander Wong
Alexander Wong
DPDoina Precup
Doina Precup
While significant research advances have been made in the field of deep reinforcement learning, there have been no concrete adversarial attack strategies in literature tailored for studying the vulnerability of deep reinforcement learning algorithms to membership inference attacks. In such attacking systems, the adversary targets the set of collected input data on which the deep reinforcement learning algorithm has been trained. To address this gap, we propose an adversarial attack framework designed for testing the vulnerability of a state-of-the-art deep reinforcement learning algorithm to a membership inference attack. In particular, we design a series of experiments to investigate the impact of temporal correlation, which naturally exists in reinforcement learning training data, on the probability of information leakage. Moreover, we compare the performance of \emph{collective} and \emph{individual} membership attacks against the deep reinforcement learning algorithm. Experimental results show that the proposed adversarial attack framework is surprisingly effective at inferring data with an accuracy exceeding $84\%$ in individual and $97\%$ in collective modes in three different continuous control Mujoco tasks, which raises serious privacy concerns in this regard. Finally, we show that the learning state of the reinforcement learning algorithm influences the level of privacy breaches significantly.